monarch: chemo-free options for triple-positive metastatic breast cancer
Published 4 years ago • 1.5K plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
0:56
potential chemo-free therapy in triple-positive mbc with ribociclib
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
5:37
metastatic breast cancer at esmo 2022: tropics02, monarch 3 and synergy
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
1:57
monarcher: final os results of abemaciclib in hr , her breast cancer
-
2:35
treatment options for high risk early breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
8:39
final overall survival analysis of monarch 1
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
2:45
trial updates in breast cancer from asco: tailorx, pakt, monarch 2 & monaleesa-3
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer